Heartbeam Inc (BEAT) Stock Price, Quote & News

Company Profile

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recordi...

Industry: Health Information Services

Sector: Healthcare

Phone: 408 899 4443

Website: www.heartbeam.com

Address:

2118 Walsh Avenue, Suite 210, Santa Clara, United States

fiat1234 Jun. 23 at 3:10 PM

$BEAT Turning out to be a real POS

0 · Reply

Jparkhill Jun. 23 at 12:57 PM

$BEAT

1 · Reply

BrightStars Jun. 23 at 10:20 AM

$BEAT this needs to go up.

0 · Reply

Aminovich87 Jun. 22 at 10:57 PM

$BEAT Patience guys! I see this stock goes back to $4 in two to three months

2 · Reply

Rumpelnickeldime Jun. 22 at 8:15 PM

$BEAT over the last year and a half the true power house stocks are memory manufacturers and still are. Not one post here about that. Y’all are literally the biggest losers in history putting your money here. So sad I can’t even laugh.

1 · Reply

Rumpelnickeldime Jun. 22 at 8:11 PM

$BEAT dead heading to zero.🤣

0 · Reply

NetworkNewsWire Jun. 22 at 6:51 PM

$BEAT Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection https://ibn.fm/3OCvC

1 · Reply

nhadar Jun. 22 at 6:05 PM

$BEAT who the hell is selling at this price mine as well let her go

0 · Reply

nhadar Jun. 22 at 3:02 PM

$BEAT loser

0 · Reply

BrightStars Jun. 22 at 11:53 AM

$BEAT thank you to whom ever is buying. Buy more ! 😊

0 · Reply

HeartBeam Proxy statement: Proxy filing

Jun 5, 2026, 8:00 AM EDT - 18 days ago

HeartBeam Proxy statement: Proxy filing

Jun 5, 2026, 7:00 AM EDT - 18 days ago

HeartBeam Slides: Investor presentation

2026-06-02T11:05:34.000Z - 21 days ago

HeartBeam announces peer-reviewed article in JACC on HeartBeam ECG

Jun 2, 2026, 7:00 AM EDT - 21 days ago

HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home

2026-05-22T10:10:58.000Z - 4 weeks ago

HeartBeam price target lowered to $2.50 from $5.50 at H.C. Wainwright

2026-05-15T14:03:56.000Z - 5 weeks ago

HeartBeam price target lowered to $5 from $8 at Benchmark

May 13, 2026, 4:30 PM EDT - 5 weeks ago

HeartBeam Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 5 weeks ago

HeartBeam Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 5 weeks ago

HeartBeam Slides: Q1 2026

May 13, 2026, 4:30 PM EDT - 5 weeks ago

HeartBeam Earnings release: Q1 2026

2026-05-13T20:08:51.000Z - 5 weeks ago

HeartBeam reports Q1 EPS (12c) vs. (18c) last year

May 13, 2026, 4:01 PM EDT - 5 weeks ago

HeartBeam Reports First Quarter 2026 Results

2026-05-11T15:12:35.000Z - 6 weeks ago

HeartBeam initiates pilot study of first on-demand 12-lead ECG patch

May 11, 2026, 8:31 AM EDT - 6 weeks ago

HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic

2026-05-07T20:27:33.000Z - 6 weeks ago

HeartBeam announces commercial agreement with Atelier Health

May 7, 2026, 8:31 AM EDT - 6 weeks ago

HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice

Apr 30, 2026, 8:31 AM EDT - 7 weeks ago

HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time

2026-04-20T12:02:38.000Z - 2 months ago

HeartBeam downgraded to Hold from Buy at D. Boral Capital

Apr 16, 2026, 4:05 PM EDT - 2 months ago

HeartBeam Announces Closing of $10 Million Public Offering of Common Stock

Apr 16, 2026, 7:00 AM EDT - 2 months ago

HeartBeam Slides: Investor presentation

2026-04-15T09:55:54.000Z - 2 months ago

HeartBeam 12.5M share Spot Secondary priced at 80c

Apr 14, 2026, 10:00 PM EDT - 2 months ago

HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock

2026-04-14T20:10:16.000Z - 2 months ago

HeartBeam announces common stock offering, no amount given

Apr 14, 2026, 4:05 PM EDT - 2 months ago

HeartBeam Announces Proposed Public Offering of Common Stock

2026-03-31T09:40:38.000Z - 3 months ago

HeartBeam initiated with a Buy at B. Riley

2026-03-31T09:20:14.000Z - 3 months ago

HeartBeam initiated with a Buy at Stifel

2026-03-27T12:37:18.000Z - 3 months ago

HeartBeam initiated with a Buy at D. Boral Capital

Mar 16, 2026, 11:20 AM EDT - 3 months ago

HeartBeam Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 13, 2026, 8:00 AM EDT - 3 months ago

HeartBeam Registration statement: Registration Filing

Mar 12, 2026, 4:30 PM EDT - 3 months ago

HeartBeam Earnings Call Transcript: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 3 months ago

HeartBeam Earnings release: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 3 months ago

HeartBeam Annual report: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 3 months ago

HeartBeam Slides: Q4 2025

2026-03-12T20:05:25.000Z - 3 months ago

HeartBeam reports Q4 EPS (62c) vs (73c) last year

Mar 12, 2026, 4:01 PM EDT - 3 months ago

HeartBeam Reports Fourth Quarter and Full Year 2025 Results

Mar 12, 2026, 7:00 AM EDT - 3 months ago

HeartBeam Slides: Investor presentation

2026-03-10T11:27:46.000Z - 3 months ago

HeartBeam announces AI pact with Icahn School of Medicine at Mount Sinai

Mar 10, 2026, 7:00 AM EDT - 3 months ago

HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home

Mar 9, 2026, 7:00 AM EDT - 3 months ago

HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch

2026-03-05T12:22:48.000Z - 3 months ago

HeartBeam enrolls first patients in ALIGN-ACS pilot study

Mar 5, 2026, 7:00 AM EST - 3 months ago

HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study

Mar 4, 2026, 4:01 PM EST - 3 months ago

HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time

2026-03-04T13:38:09.000Z - 3 months ago

HeartBeam announces investment from, partnership with ClearCardio

Mar 4, 2026, 7:00 AM EST - 3 months ago

HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market

2026-02-09T21:11:23.000Z - 4 months ago

HeartBeam files $100M mixed securities shelf

Feb 9, 2026, 7:00 AM EST - 4 months ago

HeartBeam Registration statement: Registration Filing

2026-01-22T12:26:16.000Z - 5 months ago

HeartBeam appoints Bryan Humbarger as chief commercial officer

Jan 22, 2026, 7:00 AM EST - 5 months ago

HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer

Jan 5, 2026, 7:00 AM EST - 6 months ago

HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference

Dec 10, 2025, 7:00 AM EST - 6 months ago

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

Nov 26, 2025, 4:32 PM EST - 7 months ago

HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application

Nov 13, 2025, 4:30 PM EST - 7 months ago

HeartBeam Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

HeartBeam Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

HeartBeam Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

HeartBeam Slides: Q3 2025

Nov 13, 2025, 4:01 PM EST - 7 months ago

HeartBeam Reports Third Quarter 2025 Results

Oct 30, 2025, 7:00 AM EDT - 8 months ago

HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time

Oct 28, 2025, 7:00 AM EDT - 8 months ago

HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere

Sep 8, 2025, 7:00 AM EDT - 10 months ago

HeartBeam's Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias

Aug 28, 2025, 7:00 AM EDT - 10 months ago

HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

HeartBeam Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

HeartBeam Earnings release: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

HeartBeam Quarterly report: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

HeartBeam Slides: Q2 2025

Aug 13, 2025, 4:01 PM EDT - 11 months ago

HeartBeam Reports Second Quarter 2025 Results

Jul 30, 2025, 7:00 AM EDT - 11 months ago

HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time

Jul 22, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology

Jun 24, 2025, 2:00 PM EDT - 1 year ago

HeartBeam Transcript: IAccess Alpha Virtual Best Ideas Summer Investment Conference 2025

Jun 17, 2025, 7:00 AM EDT - 1 year ago

HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025

May 29, 2025, 8:00 AM EDT - 1 year ago

HeartBeam Proxy statement: Proxy Filing

May 19, 2025, 8:00 AM EDT - 1 year ago

HeartBeam Proxy statement: Proxy Filing

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Slides: Q1 2025

May 13, 2025, 4:01 PM EDT - 1 year ago

HeartBeam Reports First Quarter 2025 Results

May 6, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

May 5, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

May 1, 2025, 8:31 AM EDT - 1 year ago

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

Apr 29, 2025, 8:31 AM EDT - 1 year ago

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

Apr 24, 2025, 8:31 AM EDT - 1 year ago

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q4 2024

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Annual report: Q4 2024

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings release: Q4 2024

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Slides: Q4 2024

Mar 13, 2025, 4:01 PM EDT - 1 year ago

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

Mar 6, 2025, 9:01 AM EST - 1 year ago

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

Feb 27, 2025, 8:31 AM EST - 1 year ago

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time

Feb 25, 2025, 4:01 PM EST - 1 year ago

HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock

Feb 13, 2025, 8:31 AM EST - 1 year ago

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

Jan 29, 2025, 8:31 AM EST - 1 year ago

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

Dec 23, 2024, 8:31 AM EST - 1 year ago

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

Dec 16, 2024, 8:31 AM EST - 1 year ago

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

Nov 19, 2024, 8:31 AM EST - 1 year ago

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Slides: Q3 2024

Nov 7, 2024, 4:05 PM EST - 1 year ago

HeartBeam Reports Third Quarter 2024 Results

Oct 31, 2024, 8:31 AM EDT - 1 year ago

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

Oct 24, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards

Oct 17, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

Sep 24, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

Sep 10, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Names Timothy Cruickshank as Chief Financial Officer

Aug 14, 2024, 4:30 PM EDT - 2 years ago

HeartBeam Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

HeartBeam Quarterly report: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

HeartBeam Earnings release: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

HeartBeam Slides: Q2 2024

Aug 14, 2024, 4:05 PM EDT - 2 years ago

HeartBeam Reports Second Quarter 2024 Results

Aug 1, 2024, 8:31 AM EDT - 2 years ago

HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

fiat1234 Jun. 23 at 3:10 PM

$BEAT Turning out to be a real POS

0 · Reply

Jparkhill Jun. 23 at 12:57 PM

$BEAT

1 · Reply

BrightStars Jun. 23 at 10:20 AM

$BEAT this needs to go up.

0 · Reply

Aminovich87 Jun. 22 at 10:57 PM

$BEAT Patience guys! I see this stock goes back to $4 in two to three months

2 · Reply

Rumpelnickeldime Jun. 22 at 8:15 PM

1 · Reply

Rumpelnickeldime Jun. 22 at 8:11 PM

$BEAT dead heading to zero.🤣

0 · Reply

NetworkNewsWire Jun. 22 at 6:51 PM

$BEAT Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection https://ibn.fm/3OCvC

1 · Reply

nhadar Jun. 22 at 6:05 PM

$BEAT who the hell is selling at this price mine as well let her go

0 · Reply

nhadar Jun. 22 at 3:02 PM

$BEAT loser

0 · Reply

BrightStars Jun. 22 at 11:53 AM

$BEAT thank you to whom ever is buying. Buy more ! 😊

0 · Reply

nottoday800 Jun. 18 at 11:51 PM

$BEAT fda approval comimg

4 · Reply

Stephanovich7654568 Jun. 18 at 11:26 PM

$BEAT Try RCKT. 358% more volume. Just saying. ❤️

0 · Reply

TradingQ2025 Jun. 18 at 8:02 PM

$BEAT do you see those huge orders!!?? 10K, 62k,317K, 6K all at 4pm

1 · Reply

nhadar Jun. 18 at 7:54 PM

$BEAT what was that

3 · Reply

BrightStars Jun. 18 at 3:24 PM

$BEAT these guys beat the last consensus but the stock price still dropped. This won’t budge north until 30,000+ subscribers are in the works. 2027 Man this sucks ! It will be great after the trials are complete and then the next large trials are complete and then the FDA approval.. IDK …2029? 😱 OMG !!!!! If they would just get this above $1.00! Please ! ..WITHOUT A REVERSE SPLIT

2 · Reply

BrightStars Jun. 18 at 3:08 PM

$BEAT I hope the forecast for the EPS is lower than .09c per share and BEAT beats the analysts predictions. So we wait for …August 😑 ugh

0 · Reply

Sacrificed Jun. 18 at 1:44 PM

$BEAT barcoding isn’t good. Can we go back to not being FDA approved?

0 · Reply

Syncor Jun. 18 at 2:48 AM

$BEAT i wish i saw this before i listened to my stupid cardiologist and invested in this loser https://m.youtube.com/watch?v=W3ts4Dwgn1k

1 · Reply

TheRoost3r Jun. 18 at 1:17 AM

$BEAT I mean

0 · Reply

Bigtimesmalltimeinvestor Jun. 18 at 12:45 AM

$BEAT For the love of God , this can’t possibly go up ???? We were over $2 before FDA approval.

0 · Reply

nhadar Jun. 17 at 7:56 PM

$BEAT everyday 1/3% down as usual

0 · Reply

fiat1234 Jun. 17 at 2:47 PM

$BEAT There is no good news for the company to report. Complete silence as share price gradually swirl in the toilet.

1 · Reply

Market Cap	42.16M
Revenue (ttm)	0.00
Net Income (ttm)	-21.02M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	466,400
Avg Vol	1,074,538
Day's Range	N/A - N/A
Shares Out	55.51M
Stochastic %K	8%
Beta	-0.86
Analysts	Sell
Price Target	$3.83